Literature DB >> 1538182

Treatment of delirium in a terminally ill patient.

R Fainsinger, E Bruera.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1538182     DOI： 10.1016/0885-3924(92)90108-t

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN： 0885-3924            Impact factor:   3.612


× No keyword cloud information.
  7 in total

1.  Efficacy and safety of deep, continuous palliative sedation at home: a retrospective, single-institution study.

Authors:  Giampiero Porzio; Federica Aielli; Lucilla Verna; Giovanna Micolucci; Paolo Aloisi; Corrado Ficorella
Journal:  Support Care Cancer       Date:  2009-04-03       Impact factor: 3.603

2.  A retrospective study of the psychiatric management and outcome of delirium in the cancer patient.

Authors:  S M Olofsson; M A Weitzner; A D Valentine; W F Baile; C A Meyers
Journal:  Support Care Cancer       Date:  1996-09       Impact factor: 3.603

Review 3.  Clarifying delirium management: practical, evidenced-based, expert recommendations for clinical practice.

Authors:  Scott A Irwin; Rosene D Pirrello; Jeremy M Hirst; Gary T Buckholz; Frank D Ferris
Journal:  J Palliat Med       Date:  2013-03-12       Impact factor: 2.947

Review 4.  Identifying patients at risk for, and treatment of major psychiatric complications of cancer.

Authors:  W Breitbart
Journal:  Support Care Cancer       Date:  1995-01       Impact factor: 3.603

5.  The efficacy of antipsychotics for prolonged delirium with renal dysfunction.

Authors:  Satoko Asano; Yasuto Kunii; Hiroshi Hoshino; Yusuke Osakabe; Tetsuya Shiga; Shuntaro Itagaki; Itaru Miura; Hirooki Yabe
Journal:  Neuropsychiatr Dis Treat       Date:  2017-11-16       Impact factor: 2.570

Review 6.  Delirium in Palliative Care.

Authors:  Patricia Bramati; Eduardo Bruera
Journal:  Cancers (Basel)       Date:  2021-11-23       Impact factor: 6.639

7.  Evidence for the use of Levomepromazine for symptom control in the palliative care setting: a systematic review.

Authors:  Isabel Dietz; Andrea Schmitz; Ingrid Lampey; Christian Schulz
Journal:  BMC Palliat Care       Date:  2013-01-19       Impact factor: 3.234
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.